Correct Skidoo.. I have met Frank Orlowski and found him to be a wonderful man. He is honest and upfront and speaks to you man to man or man to woman in a PROFESSIONAL MANNER. He does not hide behind a mask and spew what would be considered random garbage. But instead looks you in the eye and tells you what it his intentions are.
He is a VP for Pfizer Pharmaceutical and is in this position because of an exemplary work history. When reading his bio you will find he seeks out new and undiscovered new company's. And like many hundreds of executives in the business world he puts his expertise to use for many company's who are not considered competitors to his parent company Pfizer.
We as a company are thrilled to have him join the company in an advisory position and I am confident his worth to all of the shareholders will be proven in time if the right opportunity(s) should come along.
Name calling and miss leading information is part of the landscape when a company does business on the OTC like Tauriga Sciences does. Its a side effect of being here, but its the best place for emerging company's to get started. All one need do is REAL Due Diligence and you will see there are an awful lot of company's on the AMEX, NYSE and the NASDAQ who got their start on the OTC.
By bringing in top of the line people like Kieth Berman and Frank Orlowski Seth Shaw is trying extremely hard to ensure his shareholders have the best opportunity at being invested in a winning stock. We are grateful to all of the loyal shareholders who have invested in this company. Those who make decisions for themselves and know what THEY want in a stock... without having to be told what is good or bad..when to buy or sell, but actual decision makers ...these are the true investors of TAUG and we thank them one and all.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.